National Center for HIV, Viral Hepatitis, STD, and TB Prevention
National Center for HIV, Viral Hepatitis, STD, and TB Prevention datasets in the CDC Open Data Catalog
This page contains all datasets in the National Center for HIV, Viral Hepatitis, STD, and TB Prevention category of the CDC Open Data Catalog.
Total Datasets in Category: 2 Last Updated: 2/6/2026
HepTracker Dashboard
Description: This is the underlying dataset for HepTracker (https://www.cdc.gov/hepatitis/php/data-research/heptracker/index.html), which is an interactive dashboard and allows for the timely release of viral hepatitis data. HepTracker provides users the ability to view national case surveillance and viral hepatitis–related mortality data for hepatitis A, hepatitis B, and hepatitis C. Data available on the dashboard are from CDC’s National Notifiable Diseases Surveillance System (NNDSS) (https://www.cdc.gov/nndss/about/index.html) and the National Vital Statistics System (NVSS)(https://www.cdc.gov/nchs/nvss/index.htm). The dataset includes counts and rates for cases and deaths across multiple years, stratified by jurisdiction, race and ethnicity, age groups, and sex. Risk and exposure information is available for acute infections only. These data are important for understanding viral hepatitis trends, informing and developing effective public health programs, and monitoring progress toward eliminating viral hepatitis as a public health threat in the United States. For more information about these data, please see Technical Notes (https://www.cdc.gov/hepatitis/php/data-research/methodology.html).
Snowflake Schema: dwv_nch_prev
Databricks Schema: cdc_dwv_nch_prev
Table Name: heptracker_dashboard_his_identifier_is___jkcx_ndu8
Dataset ID: jkcx-ndu8
Category: National Center for HIV, Viral Hepatitis, STD, and TB Prevention
Total Rows: 8,588
Last Refresh: 1/31/2026
Total Batches: 1
Tags: hepatitis a, hepatitis b, hepatitis c, heptracker, surveillance
Source Data: https://data.cdc.gov/d/jkcx-ndu8
Hepatitis C: Commercial Laboratory Residual Sera, November 2023–September 2024
Description: This dataset provides hepatitis C virus antibody and RNA test results from all 50 states and the District of Columbia using a convenience sample of de-duplicated, deidentified residual serum specimens from a large commercial laboratory. Specimens were collected for any routine clinical screening or diagnostic testing purposes and were tested for hepatitis C virus during November 2023 through September 2024 proportional to the percent of the U.S. population in each jurisdiction and stratified by two age groups (18–≤49 years and 50–≤75 years) within sex. Specimens with reactive or equivocal hepatitis C virus antibody results were reflexed to HCV RNA testing. These data underly the manuscript published in Clinical Infectious Diseases, “Estimated hepatitis C prevalence and viral clearance using residual sera from a large commercial laboratory — November 2023–September 2024” (doi 10.1093/cid/ciag007).
Data Limitations:
Generalizability. Persons who had blood drawn for routine screening or clinical care by a single commercial laboratory might not be representative of the general U.S. adult population.
Convenience sampling is subject to potential biases.
Specimens from carceral facilities or incarcerated persons are not representative of the overall carceral population in the United States; carceral specimens are overrepresented from some jurisdictions and underrepresented from others.
Snowflake Schema: dwv_nch_prev
Databricks Schema: cdc_dwv_nch_prev
Table Name: hepatitis_c_commercial_laboratory_resid__b4ji_baqh
Dataset ID: b4ji-baqh
Category: National Center for HIV, Viral Hepatitis, STD, and TB Prevention
Total Rows: 81,483
Last Refresh: 1/16/2026
Total Batches: 1
Tags: commercial laboratory, hcv antibody, hcv rna, hepatitis c, remnant sera
Source Data: https://data.cdc.gov/d/b4ji-baqh
Last updated